Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles B Simone

Showing results (641-650 of 680) with videos related to

Pageof 68
Sort By:
Practical Radiation Oncology|April 19, 2023
Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert PanelLindsay L Puckett, Mohammad Titi, Ksenija Kujundzic, et al.
Practical Radiation Oncology|June 16, 2026
Prophylactic versus therapeutic sucralfate in patients at high risk for radiation esophagitis: randomized controlled trialJacob Y Shin, Melissa Assel, Abraham J Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation TrialAndreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2023
Stereotactic body radiation therapy versus conventional external beam radiotherapy for spinal metastases: A systematic review and meta-analysis of randomized controlled trialsHenry C Y Wong, Shing Fung Lee, Adrian Wai Chan, et al.
Annals of Palliative Medicine|April 22, 2024
A phase II trial on radiotherapy for high-risk asymptomatic bone metastases-creating more questions than answers?Adrian Wai Chan, Charles B Simone, Joanne M van der Velden, et al.
Annals of Palliative Medicine|April 11, 2025
Impact of recent clinical trials on meta-analysis of stereotactic body radiation therapy for spine metastases and urgent call for consistent study endpointsHenry C Y Wong, Shing Fung Lee, Samuel Ryu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2026
Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Non-Squamous Non-Small Cell Lung Cancer Treated with Chemoradiation and ImmunotherapyNikhil P Mankuzhy, Valentina Santo, Jacob Y Shin, et al.
Cancer|October 15, 2016
Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumorsVivek Verma, Valerie K Shostrom, Sameera S Kumar, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung CancerNikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Cancer|January 31, 2024
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab eraMichelle Iocolano, Nikhil Yegya-Raman, Cole Friedes, et al.
Pageof 68

Showing results (641-650 of 680) with videos related to

Sort By:
Pageof 68
Practical Radiation Oncology|April 19, 2023
Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert PanelLindsay L Puckett, Mohammad Titi, Ksenija Kujundzic, et al.
Practical Radiation Oncology|June 16, 2026
Prophylactic versus therapeutic sucralfate in patients at high risk for radiation esophagitis: randomized controlled trialJacob Y Shin, Melissa Assel, Abraham J Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation TrialAndreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2023
Stereotactic body radiation therapy versus conventional external beam radiotherapy for spinal metastases: A systematic review and meta-analysis of randomized controlled trialsHenry C Y Wong, Shing Fung Lee, Adrian Wai Chan, et al.
Annals of Palliative Medicine|April 22, 2024
A phase II trial on radiotherapy for high-risk asymptomatic bone metastases-creating more questions than answers?Adrian Wai Chan, Charles B Simone, Joanne M van der Velden, et al.
Annals of Palliative Medicine|April 11, 2025
Impact of recent clinical trials on meta-analysis of stereotactic body radiation therapy for spine metastases and urgent call for consistent study endpointsHenry C Y Wong, Shing Fung Lee, Samuel Ryu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2026
Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Non-Squamous Non-Small Cell Lung Cancer Treated with Chemoradiation and ImmunotherapyNikhil P Mankuzhy, Valentina Santo, Jacob Y Shin, et al.
Cancer|October 15, 2016
Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumorsVivek Verma, Valerie K Shostrom, Sameera S Kumar, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung CancerNikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Cancer|January 31, 2024
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab eraMichelle Iocolano, Nikhil Yegya-Raman, Cole Friedes, et al.
Pageof 68